New data has shown that Amanita Muscaria extract (AME-1) has a potential new functional property – inhibiting human mast cell activation – which could hold promise...
A clinical trial investigating the safety and tolerability of a novel formulation of 5-MeO-DMT in psychedelic-naive subjects has dosed its first cohort of volunteers.
The first ketamine clinic in the UK has received approval from the Care Quality Commission (CQC) to begin treatments.
UK MP Crispin Blunt raised the question of rescheduling psilocybin in Parliament this week after PM Boris Johnson gave Blunt personal reassurance back in May that...
A philanthropic programme with a focus on the psychedelic sector has been launched to harness the power of innovative mental health approaches for social change.
With limited treatment options available for the condition, one company is setting out to explore the neurogenic potential of psychedelics to combat the cognitive decline of...
Meet Delic, a psychedelic and wellness event and expo for newcomers and veterans in the psychedelics space will take place in AREA15 in Las Vegas, this...
Currently, there is no cure for Parkinson’s Disease, however, certain medications can help improve symtoms.
Real-time quantification of brain activity during the psychedelic experience has been a major barrier within psychedelic research.
Seattle council has unanimously voted to pass a resolution to decriminalise entheogenic substances.
